Drug recall · February 22, 2023
Thiamine Hydrochloride 3000 mg/30 mL recall
Why: Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Thiamine Hydrochloride 3000 mg/30 mL (100mg/mL), Riboflavin 30 mg/30 mL (1mg/mL) Injection, FOR INTRAMUSCULAR OR SLOW INTRAVENOUS USE, 30 mL Sterile Multiple Use Vial, Rx Only, Compounded for a licensed professional or patient use by: McGuff Compounding Pharmacy Services, Inc, Santa Ana, CA 92704.
- Lots / codes
Lot: 22K1661, initial BUD: 12/18/2022, extended BUD: 1/27/2023; 22J2401, BUD: 12/19/2022.
- Quantity
- 255 vials
- Company
- McGuff Compounding Pharmacy Services, Inc., Santa Ana, CA
- Distribution
- Nationwide in the USA
- Initiated
- December 8, 2022 · Voluntary: Firm initiated
- Classified
- February 10, 2023
- Reported
- February 22, 2023
- Ended
- April 27, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Thiamine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.